Skip to main content
    S

    Sionna Therapeutics, Inc. Common Stock (SION)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.12
    -0.21 (-6.31%)

    Market Cap: $150.63M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sionna Therapeutics, Inc. Common Stock (SION) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Sionna Therapeutics, Inc. Common Stock (SION) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Sionna Therapeutics, Inc. Common Stock reported EPS of -$0.72, below the -$0.62 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    38%(3/8)
    Avg Surprise
    -5.94%

    Upcoming Estimates

    Reports Mar 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.58
    Range-$0.78 - -$0.33
    13 analysts
    Revenue Consensus
    N/A
    RangeN/A
    13 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.51
    Range-$0.72 - -$0.41
    5 analysts
    EPS Revisions
    3
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.62+17.7%
    60d ago-$0.62+17.7%
    30d ago-$0.44-15.9%
    7d ago-$0.44-15.9%
    Current-$0.51
    Revenue Consensus
    N/A
    RangeN/A
    7 analysts

    Next Report

    SION has an expected report date of Mar 1, 2027.

    Earnings History

    Of the 8 quarters below that had an estimate, SION beat 3 and missed 5. The widest gap in the table came in the quarter ended Mar 31, 2025, when EPS landed 37.78% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.72-$0.62-$0.84 - -$0.53-16.13%MissN/A82 up, 1 downNov 10, 2026
    Jun 30, 2026-$0.66-$0.64-$0.69 - -$0.61-3.13%MissN/A90 up, 6 downAug 6, 2026
    Mar 31, 2026-$0.60-$0.50-$0.57 - -$0.47-20.00%MissN/A81 up, 2 downMay 12, 2026
    Dec 31, 2025-$0.46-$0.71-$0.71 - -$0.47+35.21%BeatN/A80 up, 2 downMar 2, 2026
    Sep 30, 2025-$0.46-$0.52N/A+11.54%BeatN/A21 up, 1 downNov 5, 2025
    Jun 30, 2025-$0.41-$0.45-$0.49 - -$0.44+8.89%BeatN/A21 up, 1 downAug 11, 2025
    Mar 31, 2025-$0.62-$0.45N/A-37.78%MissN/AN/AN/AMay 12, 2025
    Dec 31, 2024-$3.38-$2.68N/A-26.12%MissN/AN/AN/AMar 20, 2025
    Last 8 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026-$1.98N/A
    Jun 30, 2026-$1.26N/A
    Dec 31, 2025-$1.95N/A
    Jun 30, 2025-$1.03N/A
    Dec 31, 2024-$3.38N/A

    Frequently Asked Questions About SION

    When is Sionna Therapeutics, Inc. Common Stock's next earnings date?

    Sionna Therapeutics, Inc. Common Stock's next earnings report is expected for Mar 1, 2027.

    Did SION beat earnings estimates last quarter?

    No. Sionna Therapeutics, Inc. Common Stock reported EPS of -$0.72 for the quarter ended Sep 30, 2026, below the -$0.62 estimate by 16.13%.

    What EPS do analysts expect from SION next quarter?

    The consensus EPS estimate for Sionna Therapeutics, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.58 from 13 analysts, with estimates from -$0.78 to -$0.33.

    How often does SION beat earnings estimates?

    Sionna Therapeutics, Inc. Common Stock beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -5.94%.